BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25202008)

  • 1. The LQLP calcineurin docking site is a major determinant of the calcium-dependent activation of human TRESK background K+ channel.
    Czirják G; Enyedi P
    J Biol Chem; 2014 Oct; 289(43):29506-18. PubMed ID: 25202008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of calcineurin to an NFAT-like docking site is required for the calcium-dependent activation of the background K+ channel, TRESK.
    Czirják G; Enyedi P
    J Biol Chem; 2006 May; 281(21):14677-82. PubMed ID: 16569637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRESK (K2P18.1) Background Potassium Channel Is Activated by Novel-Type Protein Kinase C via Dephosphorylation.
    Pergel E; Lengyel M; Enyedi P; Czirják G
    Mol Pharmacol; 2019 Jun; 95(6):661-672. PubMed ID: 30992311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRESK background K(+) channel is inhibited by phosphorylation via two distinct pathways.
    Czirják G; Enyedi P
    J Biol Chem; 2010 May; 285(19):14549-57. PubMed ID: 20215114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two-pore domain K+ channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin.
    Czirják G; Tóth ZE; Enyedi P
    J Biol Chem; 2004 Apr; 279(18):18550-8. PubMed ID: 14981085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubulin binds to the cytoplasmic loop of TRESK background K⁺ channel in vitro.
    Enyedi P; Veres I; Braun G; Czirják G
    PLoS One; 2014; 9(5):e97854. PubMed ID: 24830385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties, regulation, pharmacology, and functions of the K₂p channel, TRESK.
    Enyedi P; Czirják G
    Pflugers Arch; 2015 May; 467(5):945-58. PubMed ID: 25366493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRESK background K(+) channel is inhibited by PAR-1/MARK microtubule affinity-regulating kinases in Xenopus oocytes.
    Braun G; Nemcsics B; Enyedi P; Czirják G
    PLoS One; 2011; 6(12):e28119. PubMed ID: 22145024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation-dependent binding of 14-3-3 proteins controls TRESK regulation.
    Czirják G; Vuity D; Enyedi P
    J Biol Chem; 2008 Jun; 283(23):15672-80. PubMed ID: 18397886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRESK: the lone ranger of two-pore domain potassium channels.
    Enyedi P; Braun G; Czirják G
    Mol Cell Endocrinol; 2012 Apr; 353(1-2):75-81. PubMed ID: 22115960
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Pavinato L; Nematian-Ardestani E; Zonta A; De Rubeis S; Buxbaum J; Mancini C; Bruselles A; Tartaglia M; Pessia M; Tucker SJ; D'Adamo MC; Brusco A
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and state-dependent activation of TRESK (K
    Lengyel M; Dobolyi A; Czirják G; Enyedi P
    Br J Pharmacol; 2017 Jul; 174(13):2102-2113. PubMed ID: 28419410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemically Modified Derivatives of the Activator Compound Cloxyquin Exert Inhibitory Effect on TRESK (K
    Lengyel M; Erdélyi F; Pergel E; Bálint-Polonka Á; Dobolyi A; Bozsaki P; Dux M; Király K; Hegedűs T; Czirják G; Mátyus P; Enyedi P
    Mol Pharmacol; 2019 Jun; 95(6):652-660. PubMed ID: 30979812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRESK channel as a potential target to treat T-cell mediated immune dysfunction.
    Han J; Kang D
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1102-5. PubMed ID: 19852929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRESK background potassium channel is not gated at the helix bundle crossing near the cytoplasmic end of the pore.
    Lengyel M; Czirják G; Enyedi P
    PLoS One; 2018; 13(5):e0197622. PubMed ID: 29763475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc and mercuric ions distinguish TRESK from the other two-pore-domain K+ channels.
    Czirják G; Enyedi P
    Mol Pharmacol; 2006 Mar; 69(3):1024-32. PubMed ID: 16354767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical contribution of the intracellular C-terminal region to TRESK channel activity is revealed by the epithelial Na
    Debreczeni D; Baukál D; Pergel E; Veres I; Czirják G
    J Biol Chem; 2023 Jun; 299(6):104737. PubMed ID: 37084812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verapamil Inhibits TRESK (K
    Park H; Kim EJ; Ryu JH; Lee DK; Hong SG; Han J; Han J; Kang D
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29973548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K
    Monteillier A; Loucif A; Omoto K; Stevens EB; Lainez S; Saintot PP; Cao L; Pryde DC
    Bioorg Med Chem Lett; 2016 Oct; 26(20):4919-4924. PubMed ID: 27641472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord.
    Sano Y; Inamura K; Miyake A; Mochizuki S; Kitada C; Yokoi H; Nozawa K; Okada H; Matsushime H; Furuichi K
    J Biol Chem; 2003 Jul; 278(30):27406-12. PubMed ID: 12754259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.